IL288285B1 - Crystalline form of Supirocinium bromide and method of preparation - Google Patents
Crystalline form of Supirocinium bromide and method of preparationInfo
- Publication number
- IL288285B1 IL288285B1 IL288285A IL28828521A IL288285B1 IL 288285 B1 IL288285 B1 IL 288285B1 IL 288285 A IL288285 A IL 288285A IL 28828521 A IL28828521 A IL 28828521A IL 288285 B1 IL288285 B1 IL 288285B1
- Authority
- IL
- Israel
- Prior art keywords
- compound
- crystalline form
- crystal form
- content
- suspension
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/147—Saturated compounds having only one carboxyl group and containing —CHO groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyrrole Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962851880P | 2019-05-23 | 2019-05-23 | |
| PCT/JP2020/020210 WO2020235665A1 (en) | 2019-05-23 | 2020-05-22 | Crystalline form of sofpironium bromide and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL288285A IL288285A (en) | 2022-01-01 |
| IL288285B1 true IL288285B1 (en) | 2026-02-01 |
Family
ID=72146250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL288285A IL288285B1 (en) | 2019-05-23 | 2020-05-22 | Crystalline form of Supirocinium bromide and method of preparation |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US20220298108A1 (https=) |
| EP (1) | EP3972955A4 (https=) |
| JP (2) | JP6748329B1 (https=) |
| KR (1) | KR20220011671A (https=) |
| CN (1) | CN114008023B (https=) |
| AU (1) | AU2020277881B2 (https=) |
| BR (1) | BR112021023241A2 (https=) |
| CA (1) | CA3139948A1 (https=) |
| CL (1) | CL2021003047A1 (https=) |
| CO (1) | CO2021017456A2 (https=) |
| IL (1) | IL288285B1 (https=) |
| MX (1) | MX2021014163A (https=) |
| MY (1) | MY206154A (https=) |
| PH (1) | PH12021552915A1 (https=) |
| SG (1) | SG11202111678WA (https=) |
| TW (2) | TWI838531B (https=) |
| WO (1) | WO2020235665A1 (https=) |
| ZA (1) | ZA202109514B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220298108A1 (en) * | 2019-05-23 | 2022-09-22 | Kaken Pharmaceutical Co., Ltd. | Crystalline form of sofpironium bromide and preparation method thereof |
| EP4213158A1 (en) | 2020-11-13 | 2023-07-19 | Ahead Biocomputing, Co. Ltd | Information processing device, information processing method, recording medium recording information processing program, and information processing system |
| CN115925603B (zh) * | 2022-11-29 | 2025-07-22 | 山东齐都药业有限公司 | 索吡溴铵的制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007058971A2 (en) * | 2005-11-10 | 2007-05-24 | Bodor Nicholas S | Soft anticholinergic esters |
| WO2007059021A1 (en) * | 2005-11-10 | 2007-05-24 | Bodor Nicholas S | Soft anticholinergic zwitterions |
| WO2018026869A1 (en) * | 2016-08-02 | 2018-02-08 | Dermira, Inc. | Processes for making, and methods of using, glycopyrronium compounds |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7927613B2 (en) * | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
| MX357741B (es) * | 2012-07-06 | 2018-07-23 | Laboratorios Senosiain S A De C V Star | Nuevas formas sólidas de inhibidores de fosfodiesterasa tipo 5. |
| US9512166B2 (en) * | 2012-09-05 | 2016-12-06 | Amri Ssci, Llc | Cocrystals of progesterone |
| US20150259283A1 (en) * | 2014-03-13 | 2015-09-17 | Brickell Biotech, Inc. | Formulation for soft anticholinergic analogs |
| US10282282B2 (en) * | 2016-06-29 | 2019-05-07 | Synopsys, Inc. | Automated HTTP user flows simulator |
| US20220298108A1 (en) * | 2019-05-23 | 2022-09-22 | Kaken Pharmaceutical Co., Ltd. | Crystalline form of sofpironium bromide and preparation method thereof |
-
2020
- 2020-05-22 US US17/611,158 patent/US20220298108A1/en active Pending
- 2020-05-22 KR KR1020217041385A patent/KR20220011671A/ko not_active Ceased
- 2020-05-22 CA CA3139948A patent/CA3139948A1/en active Pending
- 2020-05-22 BR BR112021023241A patent/BR112021023241A2/pt unknown
- 2020-05-22 EP EP20809754.3A patent/EP3972955A4/en active Pending
- 2020-05-22 SG SG11202111678WA patent/SG11202111678WA/en unknown
- 2020-05-22 MY MYPI2021006212A patent/MY206154A/en unknown
- 2020-05-22 TW TW109117164A patent/TWI838531B/zh active
- 2020-05-22 MX MX2021014163A patent/MX2021014163A/es unknown
- 2020-05-22 AU AU2020277881A patent/AU2020277881B2/en active Active
- 2020-05-22 CN CN202080034880.8A patent/CN114008023B/zh active Active
- 2020-05-22 TW TW112144978A patent/TWI870116B/zh active
- 2020-05-22 WO PCT/JP2020/020210 patent/WO2020235665A1/en not_active Ceased
- 2020-05-22 IL IL288285A patent/IL288285B1/en unknown
- 2020-05-22 JP JP2020089283A patent/JP6748329B1/ja active Active
- 2020-08-06 JP JP2020133620A patent/JP7605598B2/ja active Active
- 2020-11-25 US US17/105,376 patent/US11566000B2/en active Active
- 2020-11-26 PH PH1/2021/552915A patent/PH12021552915A1/en unknown
-
2021
- 2021-06-30 US US17/364,445 patent/US11584715B2/en active Active
- 2021-11-18 CL CL2021003047A patent/CL2021003047A1/es unknown
- 2021-11-24 ZA ZA2021/09514A patent/ZA202109514B/en unknown
- 2021-12-20 CO CONC2021/0017456A patent/CO2021017456A2/es unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007058971A2 (en) * | 2005-11-10 | 2007-05-24 | Bodor Nicholas S | Soft anticholinergic esters |
| WO2007059021A1 (en) * | 2005-11-10 | 2007-05-24 | Bodor Nicholas S | Soft anticholinergic zwitterions |
| WO2018026869A1 (en) * | 2016-08-02 | 2018-02-08 | Dermira, Inc. | Processes for making, and methods of using, glycopyrronium compounds |
Non-Patent Citations (2)
| Title |
|---|
| JL, F. ET AL, SYNTHESIS AND PHARMACOLOGICAL EFFECTS OF NEW, N-SUBSTITUTED SOFT ANTICHOLINERGICS BASED ON GLYCOPYRROLATE, 20 June 2005 (2005-06-20) * |
| TOTH-SARUDY, E. ET AL., PREPARATION AND BIOLOGICAL EFFECTS OF PURE STEREOISOMERIC NOVEL SOFT ANTICHOLINERGICS,, 1 February 2006 (2006-02-01) * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020189856A (ja) | 2020-11-26 |
| TW202110796A (zh) | 2021-03-16 |
| CA3139948A1 (en) | 2020-11-26 |
| SG11202111678WA (en) | 2021-11-29 |
| US20210395197A1 (en) | 2021-12-23 |
| JP2020189839A (ja) | 2020-11-26 |
| AU2020277881A1 (en) | 2021-12-09 |
| CN114008023A (zh) | 2022-02-01 |
| ZA202109514B (en) | 2023-12-20 |
| US11566000B2 (en) | 2023-01-31 |
| CL2021003047A1 (es) | 2022-09-20 |
| AU2020277881B2 (en) | 2025-03-06 |
| CO2021017456A2 (es) | 2022-01-17 |
| US11584715B2 (en) | 2023-02-21 |
| EP3972955A4 (en) | 2023-07-05 |
| TW202411205A (zh) | 2024-03-16 |
| KR20220011671A (ko) | 2022-01-28 |
| CN114008023B (zh) | 2024-02-09 |
| IL288285A (en) | 2022-01-01 |
| BR112021023241A2 (pt) | 2022-01-04 |
| TWI870116B (zh) | 2025-01-11 |
| MX2021014163A (es) | 2022-01-04 |
| JP6748329B1 (ja) | 2020-08-26 |
| TWI838531B (zh) | 2024-04-11 |
| EP3972955A1 (en) | 2022-03-30 |
| JP7605598B2 (ja) | 2024-12-24 |
| US20220298108A1 (en) | 2022-09-22 |
| PH12021552915A1 (en) | 2022-04-04 |
| MY206154A (en) | 2024-12-02 |
| WO2020235665A1 (en) | 2020-11-26 |
| US20210171460A1 (en) | 2021-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11584715B2 (en) | Crystalline form of sofpironium bromide and preparation method thereof | |
| JP2021529214A (ja) | キノリノピロリジン−２−オン系誘導化合物及びその使用 | |
| EP3604302A1 (en) | Preparation of crystalline forms of (r)-7-chloro-n-(quinuclidin-3-yl)benzo(b)thiophene-2-carboxamide hydrochloride monohydrate | |
| CN102596897A (zh) | 一种n-(苯基甲基)丙酰胺衍生物的多种固体形态及制备方法 | |
| UA112847C2 (uk) | ОКСАЛАТНА СІЛЬ КОН'ЮГАТА mPEG7-O-НАЛОКСОЛУ (ВАРІАНТИ), СПОСІБ ЇЇ ОТРИМАННЯ (ВАРІАНТИ) ТА ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ | |
| KR20220143897A (ko) | 광학 분할된 트롤록스 중간체 및 그 제조 방법 | |
| CA2510280C (en) | Process for the preparation of the r,r (or s,s) configured glycopyrronium stereoisomer | |
| KR20100022081A (ko) | 결정성 로티고틴 염기 및 이의 제조 방법 | |
| Hu et al. | Resolutions of sibutramine with enantiopure tartaric acid derivatives: chiral discrimination mechanism | |
| JP2025525738A (ja) | ピラゾロピリミジンエステル化合物の結晶形態及びそれを調製する方法 | |
| KR20200036755A (ko) | (-)-시벤졸린 숙신산염의 신규한 제조 공정 | |
| KR20250111319A (ko) | 다환 구조를 포함하는 감마-아미노뷰티르산 유도체, 이의 제조 방법 및 이의 용도 | |
| HK40068368A (en) | Crystalline form of sofpironium bromide and preparation method thereof | |
| HK40068368B (zh) | 索吡溴铵的晶型及其制备方法 | |
| CN104177337B (zh) | 达比加群酯的一种中间体及其制备方法 | |
| Bassoli et al. | Enantiodifferentiation in taste perception of isovanillic derivatives | |
| HK40118106A (zh) | 奥比塞匹布的盐及其制备方法和中间体 | |
| AU2023359635A1 (en) | Polymorphs of (2s,5r)-5-(2-chlorophenyl)-1-(2'-methoxy-[1,1'-biphenyl]-4-carbonyl)pyrrolidine-2-carboxylic acid and preparation processes thereof | |
| KR20130021476A (ko) | 라미부딘 옥살레이트 및 이의 제조방법 | |
| JP2011522016A (ja) | ４−ブロモフェニル１，４−ジアザビシクロ［３．２．２］ノナン−４−カルボキシラートのフマル酸塩、この結晶形態、調製、および治療的使用 |